5558 related articles for article (PubMed ID: 3681346)
1. Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft.
Hubbell HR; Pequignot EC; Todd J; Raymond LC; Mayberry SD; Carter WA; Strayer DR
J Biol Response Mod; 1987 Oct; 6(5):525-36. PubMed ID: 3681346
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft.
Hubbell HR; Pequignot EC; Shanabrook KR; Carter WA; Williams RD; Strayer DR
Anticancer Res; 1990; 10(3):795-801. PubMed ID: 2369093
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and immunomodulatory actions of beta-interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude mice.
Hubbell HR; Kvalnes-Krick K; Carter WA; Strayer DR
Cancer Res; 1985 Jun; 45(6):2481-6. PubMed ID: 3986788
[TBL] [Abstract][Full Text] [Related]
4. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
5. Independent sensitivity of human tumor cell lines to interferon and double-stranded RNA.
Hubbell HR; Liu RS; Maxwell BL
Cancer Res; 1984 Aug; 44(8):3252-7. PubMed ID: 6204744
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft.
Hubbell HR; Vargas HE; Tsujimoto KL; Gibson GD; Pequignot EC; Bigler RD; Carter WA; Strayer DR
Cancer Immunol Immunother; 1992; 35(3):151-7. PubMed ID: 1638550
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of ampligen (mismatched double-stranded RNA) and interferons.
Carter WA; Hubbell HR; Krueger LJ; Strayer DR
J Biol Response Mod; 1985 Dec; 4(6):613-20. PubMed ID: 2418160
[TBL] [Abstract][Full Text] [Related]
8. Preclinical studies with Ampligen (mismatched double-stranded RNA).
Carter WA; Strayer DR; Hubbell HR; Brodsky I
J Biol Response Mod; 1985 Oct; 4(5):495-502. PubMed ID: 4078595
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor effect of human interferon-alpha A/D in mice (II). Activation of natural killer cells and suppression of metastasis].
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):510-5. PubMed ID: 2988456
[TBL] [Abstract][Full Text] [Related]
10. Synergistic potentiation of in vivo antitumor activity of anti-human T-leukemia immunotoxins by recombinant alpha-interferon and daunorubicin.
Yokota S; Hara H; Luo Y; Seon BK
Cancer Res; 1990 Jan; 50(1):32-7. PubMed ID: 2293557
[TBL] [Abstract][Full Text] [Related]
11. Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency.
Hill LL; Perussia B; McCue PA; Korngold R
Cancer Res; 1994 Feb; 54(3):763-70. PubMed ID: 8306339
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of intravascular mouse melanoma dissemination by recombinant human interferon alpha A/D.
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
Jpn J Cancer Res; 1986 Jan; 77(1):80-4. PubMed ID: 3082819
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
Kondo H; Tanaka N; Naomoto Y; Orita K
Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of human osteosarcomas in nude mice by human interferon-alpha: significance of dose and tumor differentiation.
Brosjö O; Bauer HC; Broström LA; Nilsson OS; Reinholt FP; Tribukait B
Cancer Res; 1987 Jan; 47(1):258-62. PubMed ID: 3466689
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
[TBL] [Abstract][Full Text] [Related]
17. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.
Hubbell HR; Boyer JE; Roane P; Burch RM
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):906-10. PubMed ID: 1846967
[TBL] [Abstract][Full Text] [Related]
19. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
20. Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18.
Nishio S; Yamada N; Ohyama H; Yamanegi K; Nakasho K; Hata M; Nakamura Y; Fukunaga S; Futani H; Yoshiya S; Ueda H; Taniguchi M; Okamura H; Terada N
Cancer Sci; 2008 Jan; 99(1):113-20. PubMed ID: 17949451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
